Copyright
©The Author(s) 2026.
World J Psychiatry. Feb 19, 2026; 16(2): 113123
Published online Feb 19, 2026. doi: 10.5498/wjp.v16.i2.113123
Published online Feb 19, 2026. doi: 10.5498/wjp.v16.i2.113123
Figure 1 Inflammatory factors and indicators of intestinal mucosal barrier function.
A-C: Inflammatory factor levels: Tumor necrosis factor-α levels before and after treatment (A); Interleukin-6 levels before and after treatment (B); and interleukin-10 levels before and after treatment (C); D-F: Indicators of intestinal mucosal barrier function: Diamine oxidase levels before and after treatment (D); D-lactate levels before and after treatment (E); Lipopolysaccharides levels before and after treatment (F). aP < 0.05; bP < 0.01; cP < 0.001. NS: Not significant; TNF-α: Tumor necrosis factor-α; IL-6: Interleukin-6; IL-10: Interleukin-10; DAO: Diamine oxidase; LPS: Lipopolysaccharides.
Figure 2 Psychological state score.
A: Self-rating anxiety scale scores before and after treatment; B: Self-rating depression scale scores before and after treatment. aP < 0.05; bP < 0.01. NS: Not significant; SAS: Self-rating anxiety scale; SDS: Self-rating depression scale.<br/>
- Citation: Wang W, Li H, Liu YP, Chen Y, Zhang XR, Wang YZ, Tian YZ. Clinical efficacy of Xifeng Huashi and its effect on mental status in patients with diarrheal irritable bowel. World J Psychiatry 2026; 16(2): 113123
- URL: https://www.wjgnet.com/2220-3206/full/v16/i2/113123.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i2.113123
